CYXTERA TECHNOLOGIES INC (CYXT) Stock Analyst Ratings
USA - NASDAQ:CYXT - US23284C1027 - Common Stock
0.065 USD
+0.02 (+55.5%)
0.0595 USD
-0.01 (-8.46%)
ChartMill assigns a Buy % Consensus number of 75% to CYXT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.34. This target is 1959.62% above the current price.
CYXT was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CYXT.
In the previous month the buy percentage consensus was at a similar level.
CYXT was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-22 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-03-20 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-03-17 | Credit Suisse | Maintains | Outperform |
| 2023-02-07 | Credit Suisse | Maintains | Outperform |
| 2022-12-22 | Truist Securities | Maintains | Buy |
| 2022-12-14 | Exane BNP Paribas | Initiate | Underperform |
| 2022-12-01 | Citigroup | Maintains | Buy |
| 2022-11-09 | UBS | Maintains | Neutral |
| 2022-11-09 | Raymond James | Maintains | Outperform |
| 2022-09-20 | Truist Securities | Maintains | Buy |
| 2022-08-24 | Citigroup | Upgrade | Neutral -> Buy |
| 2022-06-08 | Truist Securities | Maintains | Buy |
| 2022-06-06 | RBC Capital | Maintains | Outperform |
| 2022-04-07 | Credit Suisse | Initiate | Outperform |
| 2022-01-03 | UBS | Initiate | Neutral |
| 2021-12-16 | RBC Capital | Initiate | Outperform |
| 2021-12-10 | Truist Securities | Initiate | Buy |
| 2021-12-02 | Citigroup | Maintains | Neutral |
| 2021-11-18 | Raymond James | Initiate | Outperform |